about
Multifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging.Triggered self-assembly of magnetic nanoparticles.Magnetic and optical properties of multifunctional core-shell radioluminescence nanoparticles.Iron-Loaded Magnetic Nanocapsules for pH-Triggered Drug Release and MRI Imaging.Quantitative Measurement of Ligand Exchange with Small-Molecule Ligands on Iron Oxide Nanoparticles via Radioanalytical Techniques.Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescenceSuperfine powdered activated carbon (S-PAC) coatings on microfiltration membranes: Effects of milling time on contaminant removal and flux.Highly stable multi-anchored magnetic nanoparticles for optical imaging within biofilms.Synthesis and application of glycoconjugate-functionalized magnetic nanoparticles as potent anti-adhesion agents for reducing enterotoxigenic Escherichia coli infections.Synthesis of brightly PEGylated luminescent magnetic upconversion nanophosphors for deep tissue and dual MRI imaging.Aqueous dispersions of magnetite nanoparticles complexed with copolyether dispersants: experiments and theory.Stability of polydimethylsiloxane-magnetite nanoparticle dispersions against flocculation: interparticle interactions of polydisperse materials.The effect of post-synthesis aging on the ligand exchange activity of iron oxide nanoparticles.pH Triggered Recovery and Reuse of Thiolated Poly(acrylic acid) Functionalized Gold Nanoparticles with Applications in Colloidal Catalysis.Effect of bead milling on chemical and physical characteristics of activated carbons pulverized to superfine sizes.Quantitative measurement of ligand exchange on iron oxides via radiolabeled oleic acid.Bright X-ray and up-conversion nanophosphors annealed using encapsulated sintering agents for bioimaging applications.The effect of magnetically induced linear aggregates on proton transverse relaxation rates of aqueous suspensions of polymer coated magnetic nanoparticlesTargeted magnetic hyperthermiaThe formation of linear aggregates in magnetic hyperthermia: implications on specific absorption rate and magnetic anisotropyIn vitro studies of heparin-coated magnetic nanoparticles for use in the treatment of neointimal hyperplasiaBest Practices for Characterization of Magnetic Nanoparticles for Biomedical Applications
P50
Q35760777-1D49A49B-4AD6-48EC-B03F-EB7487DACE82Q36686417-6BD46FBB-8EC0-4E95-B25C-1523628C056AQ37570133-616AD23D-D4DE-4D6D-80C0-CCFBD9AAFA9FQ37705998-22B2F056-D076-4AD6-807C-622FAFF139E0Q39102326-9BC0E748-1372-4215-AD50-4C293CD1E518Q39444049-C4E9C5F8-4BB7-437E-9ACC-C33794F3B022Q39731125-5643434F-C982-494E-99F5-A93DBB28F313Q41042253-9785052D-F0B3-4244-AAB8-44110EE57F4FQ41303130-70E3744A-AA21-40A6-A076-4E3696F91855Q42763346-BE374BB7-3C6F-43F5-AF2D-FB03C20B3E1AQ44929597-A1C0BC54-3857-4235-9D10-5468E0B00E21Q44937110-1205D1FE-05D0-476E-B58B-D6B7E26DAA44Q47444279-959CA64F-05AE-4B1A-9C73-60E02A6DD1FEQ48221991-5216A935-0B71-4BA2-96F8-E3851D4D4343Q51610256-29C463D9-805B-475E-A3D4-D47042D2E657Q53469904-64DEAE62-9794-4DB0-BE6E-26733AFA9D15Q55103884-E87E694D-4202-44AD-BBC3-F2C2552382F0Q60242448-EDCE8119-D9CA-43A9-A5CD-3161B31C0E7EQ84598939-6AD29E0D-542E-4423-8813-4EB804CED458Q87756089-A4F6D5A5-F4D6-4AAB-AA51-DA7283708849Q88019219-4D336A9A-BAC4-486E-BCE1-C2B712237DEBQ90363243-1F96DBA6-C24A-459C-8103-19B4DED5EC4F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
O Thompson Mefford
@en
O Thompson Mefford
@nl
type
label
O Thompson Mefford
@en
O Thompson Mefford
@nl
prefLabel
O Thompson Mefford
@en
O Thompson Mefford
@nl
P31
P496
0000-0002-9164-2521